The estimated Net Worth of Craig Eagle is at least $475 ezer dollars as of 1 July 2024. Craig Eagle owns over 1,714 units of Guardant Health Inc stock worth over $475,216 and over the last 3 years Craig sold GH stock worth over $0.
Craig has made over 8 trades of the Guardant Health Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently Craig exercised 1,714 units of GH stock worth $42,627 on 1 July 2024.
The largest trade Craig's ever made was exercising 6,856 units of Guardant Health Inc stock on 1 October 2023 worth over $170,509. On average, Craig trades about 2,389 units every 65 days since 2021. As of 1 July 2024 Craig still owns at least 19,108 units of Guardant Health Inc stock.
You can see the complete history of Craig Eagle stock trades at the bottom of the page.
Craig's mailing address filed with the SEC is 3100, Hanover Street, Palo Alto, Santa Clara County, California, 94306, United States.
Over the last 6 years, insiders at Guardant Health Inc have traded over $2,653,630,540 worth of Guardant Health Inc stock and bought 2,438,210 units worth $45,173,576 . The most active insiders traders include Bluebird (Cayman) Ltd Softb..., Bluebird (Cayman) Ltd Svf E... és Helmy Eltoukhy. On average, Guardant Health Inc executives and independent directors trade stock every 6 days with the average trade being worth of $2,415,822. The most recent stock trade was executed by Kumud Kalia on 9 September 2024, trading 6,545 units of GH stock currently worth $162,774.
we believe conquering cancer is a big data problem. that’s why we built the world’s leading comprehensive liquid biopsy. this non-invasive tool for accessing and sequencing tumor dna is used by thousands of oncologists to help tens of thousands of advanced cancer patients. we believe the boom in cancer data acquisition we helped launch will drive important discoveries and new products. we’re working on some exciting ones, including in early detection, where the impact on patients can be profound. we’ve raised more than $500 million from investors including sequoia capital, khosla ventures, orbimed, and softbank.
Guardant Health Inc executives and other stock owners filed with the SEC include: